Dianthus Therapeutics, Inc. · NASDAQ:DNTH
McGeorge Anne sold 7,750 Dianthus Therapeutics, Inc. shares (Form 4)
Traded Aug 10, 2026 · Filed Aug 11, 2026
On Aug 10, 2026, McGeorge Anne (Director) sold 7,750 Dianthus Therapeutics, Inc. shares at an average US$109.01 for US$845K under a trading plan, leaving 0 shares. Filed Aug 11, 2026 (Form 4).
- Sold
- 7,750 shares
- Price
- US$109.01 average (US$107.58 to US$111.41)
- Value
- US$845K
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | Option exercise | 1,250 | US$19.36 | 1,250 | Direct |
| Aug 10, 2026 | Common Stock | Option exercise | 6,500 | US$11.20 | 7,750 | Direct |
| Aug 10, 2026 | Common Stock | Sale | 1,450 | US$107.58 | 6,300 | Direct |
| Aug 10, 2026 | Common Stock | Sale | 2,800 | US$108.38 | 3,500 | Direct |
| Aug 10, 2026 | Common Stock | Sale | 1,800 | US$109.30 | 1,700 | Direct |
| Aug 10, 2026 | Common Stock | Sale | 1,000 | US$110.64 | 700 | Direct |
| Aug 10, 2026 | Common Stock | Sale | 700 | US$111.41 | 0 | Direct |